CPH
Click for more information
0.00% 0.9¢ creso pharma limited

Ann: Halucenex secures agreement with R&D partner Nucro-Technics, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. edwardc
    713 Posts.
    lightbulb Created with Sketch. 138
    clock Created with Sketch.
    06/05/21
    11:39
    Post #: 52980330
    CPH announcing it as though it has already "acquired" Halucenex....




    CPH Price at posting: 20.0¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Smallcap Radiopharm notches +12% jump on pancreatic cancer imaging win
right-arrow Created with Sketch.
NEWS Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban
right-arrow Created with Sketch.
NEWS EQR looks to become 'preeminent Western tungsten producer' with key acquisition
right-arrow Created with Sketch.
NEWS Things finally 'looking different' for up-and-down Hot Stock tip Stockland
right-arrow Created with Sketch.
NEWS NAB dips 1.8% as ASIC take bank to court for ignoring hardship applications
right-arrow Created with Sketch.
NEWS 'Major potential': Nanocap Forrestania hits 222g/t gold rock chip at Bonnie Vale
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.